Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Edgewise Therapeutics Inc shares valued at $2,120,101 were sold by Russell Alan J on Sep 20 ’24. At $28.27 per share, Russell Alan J sold 75,000 shares. The insider’s holdings dropped to 12,719 shares worth approximately $0.41 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, MOORE JOHN R sold 50,000 shares, netting a total of over 1,418,510 in proceeds. Following the sale of shares at $28.37 each, the insider now holds 3,252 shares.
Before that, MOORE JOHN R had sold 20,922 shares from its account. In a trade valued at $578,064, the General Counsel traded Edgewise Therapeutics Inc shares for $27.63 each. Upon closing the transaction, the insider’s holdings decreased to 20,922 shares, worth approximately $0.1 million.
As published in their initiating research note from Evercore ISI on November 22, 2024, Edgewise Therapeutics Inc [EWTX] has been an Outperform and the price target has been revised to $45. Analysts at Piper Sandler started covering the stock with ‘”an Overweight”‘ outlook in a report released in early March. As of May 01, 2023, Truist has initiated its “Buy” rating for EWTX. Earlier on August 25, 2022, Goldman downgraded its rating. Their new recommendation was “a Sell” for EWTX stock which previously was a “a Neutral”.
Analyzing EWTX Stock Performance
During the last five days, there has been a drop of approximately -0.06%. Over the course of the year, Edgewise Therapeutics Inc shares have jumped approximately 193.05%. Shares of the company reached a 52-week high of $38.12 on 11/11/24 and a 52-week low of $9.00 on 01/17/24. A 50-day SMA is recorded $32.14, while a 200-day SMA reached $21.66. Nevertheless, trading volume fell to 0.83 million shares from 0.48 million shares the previous day.
Support And Resistance Levels for Edgewise Therapeutics Inc (EWTX)
According to the 24-hour chart, there is a support level at 31.47, which, if violated, would cause prices to drop to 30.89. In the upper region, resistance lies at 32.73. The next price resistance is at 33.41. RSI (Relative Strength Index) is 47.98 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.12, which suggests the price will decrease in the coming days. Percent R is at 46.30%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.
